Nov 15, 2023 PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
May 11, 2023 PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
Oct 7, 2022 PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
Jul 19, 2022 PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study